BIORESORBABLE IMPLANTS MARKET ANALYSIS

Regional Analysis

To learn more about this report, request sample copy

North America dominates the global bioresorbable implants market with an estimated market share of 40.2% in 2024, owing to strong presence of key players and availability of advanced healthcare facilities in the region. The U.S. accounts for majority share in the North American as well as global market. Strong focus on research and development activities coupled with growing adoption of minimally invasive surgeries can drive the market growth in the region. Moreover, favorable regulatory approvals and reimbursement policies also drives the market growth.

Asia Pacific region has emerged as the fastest growing market for bioresorbable implants. Rapidly developing healthcare infrastructure, increasing medical tourism and growing incidences of chronic diseases across major Asian countries including China, India and Japan can drive the market growth. Growing awareness about such innovative implants and improving access to healthcare attracts patients as well as international players in the region. China dominates the Asia Pacific market owing to large patient pool, reduction in treatment costs, and increase in disposable incomes.